Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03296803

Ligand	Ligand name	Chain	PDB	Tanimoto
11O	(TRANS-12,13-EPOXY)-11-HYDROXY-9(Z)-OCTADECENOIC ACID	A	1IK3	0.73
9OH	(TRANS-12,13-EPOXY)-9-HYDROXY-10(E)-OCTADECENOIC ACID	A	1IK3	0.73
5OP	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	A	2ZB4	0.76
5OP	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	A,B	1V3V	0.76
HCR	7-HYDROXYCHOLESTEROL	A	1ZHT	0.71
RCL	RICINOLEIC ACID	A	2CM4	0.74
RCL	RICINOLEIC ACID	A	2CM9	0.74
RCL	RICINOLEIC ACID	A	1FK7	0.74
OLC	(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate	A	3D4S	0.7
VD1	5-{2-[1-(1-METHYL-PROPYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1RKG	0.7
8PG	(8S,12S)-15S-HYDROXY-9-OXOPROSTA-10Z,13E-DIEN-1-OIC ACID	A,B	2G5W	0.81
O1C	2ALPHA-(3-HYDROXYPROPYL)-1ALPHA,25-DIHYDROXYVITAMIN D3	A	2HB7	0.71
9HO	(9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid	A,B	2VSR	0.74
JC1	(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2S,3S)-3-(2-hydroxyethyl)heptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexane-1,3-diol	A	2ZXN	0.71
6OB	(8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid	A,B	2VV4	0.77
PGX	7-[6-(3-HYDROPEROXY-OCT-1-ENYL)-2,3-DIOXA-BICYCLO[2.2.1]HEPT-5-YL]-HEPT-5-ENOIC ACID	A,B,C,D	1DDX	0.87
6OC	(8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid	A,B	2VV4	0.73
T24	(9Z,11E,13S,15Z)-13-hydroxyoctadeca-9,11,15-trienoic acid	A,B	3DSI	0.74
BIV	21-NOR-9,10-SECOCHOLESTA-5,7,10(19)-TRIENE-1,3,25-TRIOL, 20-(4-HYDROXY-4-METHYLPENTYL)-, (1A,3B,5Z,7E)	A	2HCD	0.7
E4H	(3R,4S,5S,7R,9E,11R,12R)-12-ETHYL-4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE	A,B	2HFK	0.71
MC9	CALCIPOTRIOL	A	1S19	0.71
243	(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid	A,B	3DSJ	0.74
243	(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid	A,B	2RCH	0.74
243	(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid	A,B	2VST	0.74
13S	13(S)-HYDROPEROXY-9(Z),11(E)-OCTADECADIENOIC ACID	A	1IK3	0.72
PG2	PROSTAGLANDIN D2	A,B	1RY0	0.85
ZBA	12,13-Epoxytrichothec-9-ene-3,4,8,15-tetrol-4,15-diacetate-8-isovalerate	A	2RKV	0.7
ZBA	12,13-Epoxytrichothec-9-ene-3,4,8,15-tetrol-4,15-diacetate-8-isovalerate	A,B,C,D	2ZBA	0.7
AFB	1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO-1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN-4-ONE	A,B,E	1R8Q	0.79
AFB	1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO-1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN-4-ONE	A	1RE0	0.79
AFB	1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO-1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN-4-ONE	A,E	1S9D	0.79
FUA	FUSIDIC ACID	A	1QCA	0.71
FUA	FUSIDIC ACID	A,B,C,D,E,F,G,H,I,J,K,L	1Q23	0.71
FUA	FUSIDIC ACID	A,B	2VUF	0.71
V2H	(1S,3R,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraene-1,3-diol	A,B	3DL9	0.72
EB1	SEOCALCITOL	A	1S0Z	0.72
KH1	5-(2-{1-[1-(4-ETHYL-4-HYDROXY-HEXYLOXY)-ETHYL]-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE}-ETHYLIDENE)-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1IE8	0.71
JB1	(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R,3S)-3-(2-hydroxyethyl)heptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexane-1,3-diol	A	2ZXM	0.71
13R	13(R)-HYDROPEROXY-9(Z),11(E)-OCTADECADIENOIC ACID	A	1IK3	0.72
LUX	(3R,3'R,6'S,9R,9'R,13R,13'S)-4',5'-DIDEHYDRO-5',6',7',8',9,9',10,10',11,11',12,12',13,13',14,14',15,15'-OCTADECAHYDRO-BETA,BETA-CAROTENE-3,3'-DIOL	A,B,C	2BHW	0.73
LUT	(3R,3'R,6S)-4,5-DIDEHYDRO-5,6-DIHYDRO-BETA,BETA-CAROTENE-3,3'-DIOL	A,B,C,D,E,F,G,H,I,J	1RWT	0.72
HO2	(9E,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid	A	3DBM	0.74
3ON	(3R)-3-HYDROXY-8'-APOCAROTENOL	A,B,C,D	2BIW	0.71
E2P	PROSTAGLANDIN B2	A	1CZ2	0.73